Search - tctmd.com

Displaying 281 - 300 of 912

Sort: Relevancy | Date

Presentation TCT 2022

TCT 772: Simultaneous Thrombotic Occlusion of all Epicardial Coronaries in a Marijuana addict

Presenter: RAVI GUPTA

September 18, 2022

Presentation TCT 2022

TCT 104: Impact of Left Ventricular Ejection Fraction (EF) on 10-year Mortality after Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Grafting (CABG) : Is CABG Safer Than PCI in all Patients With Reduced Ejection Fraction (rEF) ?

Presenter: Patrick Serruys

September 18, 2022

Presentation TCT 2022

Sirolimus-coated balloon: from EASTBOURNE, the Largest DCB study ever, to the next step, TRANSFORM 2 RCT

Presenter: Bernardo Cortese

September 18, 2022

Presentation TCT 2022

Angina - the Scope of the Problem

Presenter: Timothy Henry

September 18, 2022

Presentation TCT 2022

TCT 103: Impact of pre-existing and new atrial fibrillation on major adverse cardiac events following coronary revascularization

Presenter: Omar Abdel-Razek

September 18, 2022

Presentation TCT 2022

DCB in CAD: understanding the existing and new indications

Presenter: Antonio Colombo

September 18, 2022

Presentation TCT 2022

Sirolimus Coated Balloon with Nanolute Technology: Pre-clinical Insights and Rationale

Presenter: Aloke Finn

September 18, 2022

Presentation TCT 2022

My Approach to Left Main Coronary Disease

Presenter: Robert Riley

September 18, 2022

Presentation TCT 2022

TCT 101: Machine learning-based prediction of long-term mortality following percutaneous and surgical revascularisation in patients with complex coronary artery disease: analysis of the multicentre randomised controlled SYNTAXES trial with external…

Presenter: Patrick Serruys

September 18, 2022

Presentation TCT 2022

Keynote Lecture: Essentials of Coronary Thrombus Management

Presenter: Sanjit Jolly

September 18, 2022

Presentation TCT 2022

Introduction & Session Objectives

Presenter: Martin Leon

September 18, 2022

Presentation TCT 2022

TCT 329: Cerebral Embolic Protection Devices For Prevention Of Post-Procedural Ischemic Stroke With Transcatheter Aortic Valve Replacement: A SYSTEMATIC REVIEW AND META-ANALYSIS

Presenter: Tanesh Ayyalu

September 18, 2022

Presentation

TCT 134: Vascular healing of native coronary artery lesions following treatment with drug-coated balloons – Insights from an OCT study

Presenter: Matthias Bossard

September 18, 2022

Presentation TCT 2022

How Important Is Complete Revascularization?

Presenter: Megha Prasad

September 18, 2022

Presentation TCT 2022

TCT 328: Low-dose or Standard-dose Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombus and Cerebral Thromboembolism after Transcatheter Aortic Valve Replacement (TAVR): Subgroup Analysis of the Randomized ADAPT-TAVR Trial

Presenter: Mijin Kim

September 18, 2022

Presentation TCT 2022

TCT 133: Efficacy and Safety of Drug-coated Balloons According to Coronary Vessel Size. A Report from the BASKET-SMALL 2 Trial

Presenter: Bruno Scheller

September 18, 2022

Presentation TCT 2022

For Most Patients, Only Spontaneous MI Is Relevant

Presenter: Alexandra J. Lansky

September 18, 2022

Presentation TCT 2022

Periprocedural MI Matters to All Patients!

Presenter: Milan Milojevic

September 18, 2022

Presentation TCT 2022

TCT 327: Clinical and Radiographic Measures of Stroke-Related Outcomes with Cerebral Embolic Protection Devices During TAVR: A Meta-analysis.

Presenter: Arpanjeet Kaur

September 18, 2022

Presentation TCT 2022

TCT 132: In Vitro Benchtop Assessment of Particulate Generation from Drug-coated Balloons

Presenter: Hui Ying Ang

September 18, 2022

Advertisement

TCT 772: Simultaneous Thrombotic Occlusion of all Epicardial Coronaries in a Marijuana addict

TCT 104: Impact of Left Ventricular Ejection Fraction (EF) on 10-year Mortality after Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Grafting (CABG) : Is CABG Safer Than PCI in all Patients With Reduced Ejection Fraction (rEF) ?

Sirolimus-coated balloon: from EASTBOURNE, the Largest DCB study ever, to the next step, TRANSFORM 2 RCT

Angina - the Scope of the Problem

TCT 103: Impact of pre-existing and new atrial fibrillation on major adverse cardiac events following coronary revascularization

DCB in CAD: understanding the existing and new indications

Sirolimus Coated Balloon with Nanolute Technology: Pre-clinical Insights and Rationale

My Approach to Left Main Coronary Disease

TCT 101: Machine learning-based prediction of long-term mortality following percutaneous and surgical revascularisation in patients with complex coronary artery disease: analysis of the multicentre randomised controlled SYNTAXES trial with external…

Keynote Lecture: Essentials of Coronary Thrombus Management

Introduction & Session Objectives

TCT 329: Cerebral Embolic Protection Devices For Prevention Of Post-Procedural Ischemic Stroke With Transcatheter Aortic Valve Replacement: A SYSTEMATIC REVIEW AND META-ANALYSIS

TCT 134: Vascular healing of native coronary artery lesions following treatment with drug-coated balloons – Insights from an OCT study

How Important Is Complete Revascularization?

TCT 328: Low-dose or Standard-dose Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombus and Cerebral Thromboembolism after Transcatheter Aortic Valve Replacement (TAVR): Subgroup Analysis of the Randomized ADAPT-TAVR Trial

TCT 133: Efficacy and Safety of Drug-coated Balloons According to Coronary Vessel Size. A Report from the BASKET-SMALL 2 Trial

For Most Patients, Only Spontaneous MI Is Relevant

Periprocedural MI Matters to All Patients!

TCT 327: Clinical and Radiographic Measures of Stroke-Related Outcomes with Cerebral Embolic Protection Devices During TAVR: A Meta-analysis.

TCT 132: In Vitro Benchtop Assessment of Particulate Generation from Drug-coated Balloons

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content